Atorvastatin use in specific populations
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
Hepatic impairment: Plasma concentrations markedly increased in patients with chronic alcoholic liver disease.[1]
References
Adapted from the FDA Package Insert.